Platform
DefiniGEN Opti-HEP
Applications
Efficacy Screening
Toxicology Screening
Disease Modeling
Gene Editing Services
Cell Products
Wild-type cells
Opti-HEP: Wild-type
Opti-HSC: Hepatic Stellates
Intestinal Organoids
Disease Models
MASLD
A1ATD
Wilson’s Disease
PFIC2
Urea Cycle disorders
About
About us
Career Opportunities
News
News
Blog
Events
View all events
Resources
Resources
Blogs
Contact
Platform
DefiniGEN Opti-HEP
Applications
Efficacy Screening
Toxicology Screening
Disease Modeling
Gene Editing Services
Cell Products
Wild-type cells
Opti-HEP: Wild-type
Opti-HSC: Hepatic Stellates
Intestinal Organoids
Disease Models
MASLD
A1ATD
Wilson’s Disease
PFIC2
Urea Cycle disorders
About
About us
Career Opportunities
News
News
Blog
Events
View all events
Resources
Resources
Blogs
Contact
ASGCT 2024
7-11 May 2024 / Baltimore, MD, United States
Posted by
DefiniGEN
on
Sun, May 7, 2023
Come and meet DefiniGEN at booth #1745 and hear how our iPSC-derived hepatocyte platform (Opti-HEP):
Can be applied to any modality;
Is engineered to recapitulate disease phenotypes; and
Offers diverse genetic backgrounds for screening.